0 CHECKOUT

S&P CORRECT: Respiratory Disease SARS Chokes Asia-Pacific Growth, But Sovereign Ratings Are Secure Apr 03

  • ID: 1886867
  • April 2003
  • Standard & Poors

FEATURED COMPANIES

  • Cook Islands
  • India (Republic of)
  • Indonesia (Republic of)
  • Japan
  • Korea (Republic of)
  • Malaysia
  • MORE

Abstract
(Editor's note: In the previous version of this commentary article, reference to New Zealand in the first paragraph could have been understood to imply that there have been cases of SARS in New Zealand. So far, there have been suspected cases of the disease investigated, but no cases confirmed.) The outbreak of a deadly atypical pneumonia, known as Severe Acute Respiratory Syndrome (SARS), will lower growth rates of most economies in Asia for 2003. The gravest damage will be inflicted on Hong Kong and the least on Pakistan. The virus has spread far and wide, with cases reported from Japan to Canada. Within Asia, the virus has affected not just tourist arrivals and consumer spending, but also business operations and...

Companies mentioned in this report are:
- Australia (Commonwealth of)
- New Zealand
- Japan
- Hong Kong (Special Administrative Region)
- Malaysia
- Thailand (Kingdom of)
- Korea (Republic of)
- Singapore (Republic of)
- Taiwan (Republic of China)
- India (Republic of)
- China (People's Republic of )
- Indonesia (Republic of)
- Philippines (Republic of the)
- Pakistan (Islamic Republic of)
- Cook Islands
- READ MORE >

Note: Product cover images may vary from those shown

- Australia (Commonwealth of)
- New Zealand
- Japan
- Hong Kong (Special Administrative Region)
- Malaysia
- Thailand (Kingdom of)
- Korea (Republic of)
- Singapore (Republic of)
- Taiwan (Republic of China)
- India (Republic of)
- China (People's Republic of )
- Indonesia (Republic of)
- Philippines (Republic of the)
- Pakistan (Islamic Republic of)
- Cook Islands
- Papua New Guinea (Independent State of)
- Mongolia
- Vietnam (Socialist Republic of)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.